StockData
Aytu BioPharma, Inc logo

Aytu BioPharma, Inc (AYTU) stock

AYTUNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/3070% below fair value
$2.66+0.84 (+46.15%)

Close on Nov 17, 2026Market cap $28.91MP/E –Yield –

Aytu BioPharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Aytu BioPharma's price to sales ratio was 0.3× on Nov 11, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.1× to 0.5×, with a median of 0.2×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.1
2025Dec 31, 20250.4×+0.2
2024Dec 31, 20240.2×+0.0
2023Dec 29, 20230.2×+0.0
2022Dec 30, 20220.1×−0.4
2021Dec 31, 20210.5×−1.4
2020Dec 31, 20201.9×−0.5
2019Dec 31, 20192.4×+2.0
2018Dec 31, 20180.4×−2.3
2017Dec 29, 20172.6×+0.2
2016Dec 30, 20162.4×−203.9
2015Dec 31, 2015206.3×+102.0
2014Dec 31, 2014104.2×−87.8
2013Dec 31, 2013192.0×–

More Aytu BioPharma figures

See a number that looks wrong?